Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. DE
9. OSIS
10. REAX

Go back to Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update
(NASDAQ: MNPR) Delayed: 107.72 -3.16 (2.85%)
Previous Close $110.88    52 Week High $ 
Open $111.98    52 Week Low $ 
Day High $113.46    P/E N/A 
Day Low $105.42    EPS $ 
Volume 176,420